Kimberly Adkins
Senior Director of Manufacturing Ratio Therapeutics
Kim Adkins is a manufacturing and validation specialist with experience across Novartis, Alcon, and Texas A&M University, spanning both pharmaceutical and biotherapeutic environments. She has worked across the full drug development lifecycle—from early process development through to sterile fill and GMP manufacturing, with expertise in validation, quality systems, and aseptic processing.
Wednesday 16th September 2026
Panel Discussion: Connecting Manufacturing, Logistics, & Site Coordination Data to Improve Visibility Across the Value Chain
4:00 pm
- Mapping how data currently moves between CDMOs, logistics providers, sponsors, and sites, and identifying where fragmentation creates delays or miscommunication
- Integrating scheduling, shipment tracking, and site readiness data to improve alignment between drug availability and patient treatment windows
- Reducing manual interventions and communication gaps by creating clearer digital workflows across the supply network
Thursday 17th September 2026
Designing Robust GMP Strategies for Radiopharmaceutical Manufacturing Under 211 Expectations
3:30 pm
- Examining how teams are building processes based on PET (212) experience, while being assessed against stricter 211 standards, and what this means for facility design, validation, and audit readiness
- Exploring key challenges such as pressure cascades, isolator design, and operator protection vs product sterility; and how to design systems that satisfy both
- Strategies for building robust upfront controls to compensate for limited product testing windows
